图布林抑制剂:对抗白血病的新策略的洞察力
Sangeeta Verma1, Pankaj Gupta2, Rakesh Narang2
1Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, India.
Future medicinal chemistry
|August 19, 2025
概括
新的氨酸抑制剂通过向癌细胞增殖,对治疗白血病有前途. 研究突出了针对急性淋巴细胞白血病有效的特定分子结构,提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 白血病,一个重要的全球性癌症,需要新的治疗方法,因为耐氨酸激酶抑制剂的耐药性.
- 图布林抑制剂是一种微管向剂 (MTA) 的类别,在打击白血病细胞增殖方面表现出潜在的潜力.
研究的目的:
- 审查最近 (2018年至今) 的抗白血病氨酸抑制剂,包括合成,天然,双重/多重标剂和抗体-药物合物.
- 分析这些抗白血病抑制剂的结构-活性关系 (SAR).
主要方法:
- 从2018年到现在出版的抗白血病结核素抑制剂的文献综述.
- 对已识别的氨酸抑制剂进行结构-活性关系分析.
- 最近的专利和临床试验数据的汇编.
主要成果:
- 确定了各种类型的氨酸抑制剂,具有抗白血病潜力.
- SAR分析表明,trimethoxy phenyl, chalcone, quinoline 和 oxadiazole 支架增强了图林的抑制活性,特别是针对急性淋巴细胞白血病.
- 最近的专利和临床试验涉及抗白血病的图林抑制剂被记录下来.
结论:
- 图布林抑制剂代表了白血病治疗的有希望的策略,为传统疗法提供了替代方案.
- 特定的结构支架对于在白血病中强烈的氨酸抑制至关重要.
- 目前正在进行的研究和临床试验表明,针对针对性抗白血病的基于图林的疗法正在发展.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K


